ESMI website launch

We are excited to announce the launch of the ESMI website! This website is dedicated to providing...

AZOREAN ESMI MEMBERS TRAVEL TO GRACIOSA AND FLORES ISLANDS

Members of the Azorean ESMI team recently returned from a two-day trip to the island of Graciosa, where they conducted follow-up visits to ESMI participants from this small island.

ICAR 2024: Advancing Ataxia Research and Inspiring Progress in SCA3/MJD Therapies

ICAR 2024 brought together 600+ experts in London to discuss advances in ataxia research, including new therapies, rehabilitation trials, and promising SCA3/MJD treatments.

ESMI Annual Meeting 2024: Advancing SCA3/MJD Research in the Azores

Members of the Azorean ESMI team recently returned from a two-day trip to the island of Graciosa, where they conducted follow-up visits to ESMI participants from this small island.

ESMI Strengthens Global Impact: Representatives Elected to AGI Steering Committee

In November 2024, three ESMI representatives joined the AGI Steering Committee, with Thomas Klockgether elected as Chair.

Spinocerebellar ataxia type 3/Machado-Joseph disease, and other ataxias, in debate on Rare Disease Day

On Rare Disease Day 2025, the University of Coimbra hosted an event on SCA3/MJD, uniting patients, families, and researchers. It highlighted recent advances and emphasized collaboration to accelerate treatment development.